The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands

被引:109
作者
Tzahar, E [1 ]
Yarden, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 1998年 / 1377卷 / 01期
基金
美国国家卫生研究院;
关键词
carcinoma; growth factor; oncogene; signal transduction; receptor; tyrosine kinase;
D O I
10.1016/S0304-419X(97)00032-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:M25 / M37
页数:13
相关论文
共 120 条
[1]  
ALIMANDI M, 1995, ONCOGENE, V10, P1813
[2]   HER-2/NEU IN NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OF OVEREXPRESSION INFLUENCED BY THE PRESENCE OF INSITU CARCINOMA [J].
ALLRED, DC ;
CLARK, GM ;
TANDON, AK ;
MOLINA, R ;
TORMEY, DC ;
OSBORNE, CK ;
GILCHRIST, KW ;
MANSOUR, EG ;
ABELOFF, M ;
EUDEY, L ;
MCGUIRE, WL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :599-605
[3]   THE STRUCTURAL BASIS FOR THE SPECIFICITY OF EPIDERMAL GROWTH-FACTOR AND HEREGULIN BINDING [J].
BARBACCI, EG ;
GUARINO, BC ;
STROH, JG ;
SINGLETON, DH ;
ROSNACK, KJ ;
MOYER, JD ;
ANDREWS, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (16) :9585-9589
[4]   OVEREXPRESSION OF THE C-ERBB-2 ONCOPROTEIN - WHY DOES THIS OCCUR MORE FREQUENTLY IN DUCTAL CARCINOMA INSITU THAN IN INVASIVE MAMMARY-CARCINOMA AND IS THIS OF PROGNOSTIC-SIGNIFICANCE [J].
BARNES, DM ;
BARTKOVA, J ;
CAMPLEJOHN, RS ;
GULLICK, WJ ;
SMITH, PJ ;
MILLIS, RR .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :644-648
[5]   Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
[6]  
Baulida J, 1996, J BIOL CHEM, V271, P5251
[7]  
BEERLI RR, 1994, J BIOL CHEM, V269, P23931
[8]   Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities [J].
Beerli, RR ;
Hynes, NE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6071-6076
[9]   A SINGLE AUTOPHOSPHORYLATION SITE CONFERS ONCOGENICITY TO THE NEU/ERBB-2 RECEPTOR AND ENABLES COUPLING TO THE MAP KINASE PATHWAY [J].
BENLEVY, R ;
PATERSON, HF ;
MARSHALL, CJ ;
YARDEN, Y .
EMBO JOURNAL, 1994, 13 (14) :3302-3311
[10]  
BENLEVY R, 1992, J BIOL CHEM, V267, P17304